|
1
|
Pisano A, Griñan-Lison C, Farace C,
Fiorito G, Fenu G, Jiménez G, Scognamillo F, Peña-Martin J,
Naccarati A, Pröll J, et al: The inhibitory role of miR-486-5p on
CSC phenotype has diagnostic and prognostic potential in colorectal
cancer. Cancers (Basel). 12:34322020. View Article : Google Scholar
|
|
2
|
Giuliani J and Bonetti A: The
pharmacological costs of first-line therapies in unselected
patients with advanced colorectal cancer: A review of published
phase III trials. Clin Colorectal Cancer. 15:277–284. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao J, Huang A, Zheng X, Liu T, Lin Z,
Zhang S, Yang Q, Zhang T and Ma H: 53BP1 loss induces
chemoresistance of colorectal cancer cells to 5-fluorouracil by
inhibiting the ATM-CHK2-P53 pathway. J Cancer Res Clin Oncol.
143:419–431. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu C, Bardes EE, Jegga AG and Aronow BJ:
ToppMiR: Ranking microRNAs and their mRNA targets based on
biological functions and context. Nucleic Acids Res. 42((Web Server
Issue)): W107–W113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berindan-Neagoe I, Monroig Pdel C,
Pasculli B and Calin GA: MicroRNAome genome: A treasure for cancer
diagnosis and therapy. CA Cancer J Clin. 64:311–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao L, Shan Y, Liu B, Li Y and Jia L:
Retraction Note: Functional screen analysis reveals miR-3142 as
central regulator in chemoresistance and proliferation through
activation of the PTEN-AKT pathway in CML. Cell Death Dis.
11:1212020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Si W, Shen J, Du C, Chen D, Gu X, Li C,
Yao M, Pan J, Cheng J, Jiang D, et al: A miR-20a/MAPK1/c-Myc
regulatory feedback loop regulates breast carcinogenesis and
chemoresistance. Cell Death Differ. 25:406–420. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang B, Lu FY, Shi RH, Feng YD, Zhao XD,
Lu ZP, Xiao L, Zhou GQ, Qiu JM and Cheng CE: miR-26b regulates
5-FU-resistance in human colorectal cancer via down-regulation of
Pgp. Am J Cancer Res. 8:2518–2527. 2018.PubMed/NCBI
|
|
9
|
Bao Y, Zhang Y, Lu Y, Guo H, Dong Z, Chen
Q, Zhang X, Shen W, Chen W and Wang X: Overexpression of microRNA-9
enhances cisplatin sensitivity in hepatocellular carcinoma by
regulating EIF5A2-mediated epithelial-mesenchymal transition. Int J
Biol Sci. 16:827–837. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng Q, Xiang L, Fu J, Chu X, Wang C and
Yan B: Transcriptome profiling reveals miR-9-3p as a novel tumor
suppressor in gastric cancer. Oncotarget. 8:37321–37331. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu B, Xi X, Liu Q, Cheng Y and Yang H:
miR-9 functions as a tumor suppressor in acute myeloid leukemia by
targeting CX chemokine receptor 4. Am J Transl Res. 11:3384–3397.
2019.PubMed/NCBI
|
|
12
|
Xiong WC, Han N, Ping GF, Zheng PF, Feng
HL, Qin L and He P: microRNA-9 functions as a tumor suppressor in
colorectal cancer by targeting CXCR4. Int J Clin Exp Pathol.
11:526–536. 2018.PubMed/NCBI
|
|
13
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA and Skotheim RI: miR-9, −31, and −182 deregulation promote
proliferation and tumor cell survival in colon cancer. Neoplasia.
14:868–879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park YR, Lee ST, Kim SL, Liu YC, Lee MR,
Shin JH, Seo SY, Kim SH, Kim IH, Lee SO and Kim SW: MicroRNA-9
suppresses cell migration and invasion through downregulation of
TM4SF1 in colorectal cancer. Int J Oncol. 48:2135–2143. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Borrmann L, Schwanbeck R, Heyduk T,
Seebeck B, Rogalla P, Bullerdiek J and Wiśniewski JR: High mobility
group A2 protein and its derivatives bind a specific region of the
promoter of DNA repair gene ERCC1 and modulate its activity.
Nucleic Acids Res. 31:6841–6851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Dai M, Li Q, Wang Z, Lu Y and Song
Z: HMGA2 regulates lung cancer proliferation and metastasis. Thorac
Cancer. 8:501–510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mansoori B, Mohammadi A, Asadzadeh Z,
Shirjang S, Minouei M, Abedi Gaballu F, Shajari N, Kazemi T,
Gjerstorff MF, Duijf PHG and Baradaran B: HMGA2 and Bach-1
cooperate to promote breast cancer cell malignancy. J Cell Physiol.
234:17714–17726. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Liu X, Li AY, Chen L, Lai L, Lin
HH, Hu S, Yao L, Peng J, Loera S, et al: Overexpression of HMGA2
promotes metastasis and impacts survival of colorectal cancers.
Clin Cancer Res. 17:2570–2580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You
T: HMGA2 induces transcription factor Slug expression to promote
epithelial-to-mesenchymal transition and contributes to colon
cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu X, Wang Y, Deng H, Liu C, Wu J and Lai
M: HMGA2 enhances 5-fluorouracil chemoresistance in colorectal
cancer via the Dvl2/Wnt pathway. Oncotarget. 9:9963–9974. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang YN, Zeng ZL, Lu J, Wang Y, Liu ZX, He
MM, Zhao Q, Wang ZX, Li T, Lu YX, et al: CPT1A-mediated fatty acid
oxidation promotes colorectal cancer cell metastasis by inhibiting
anoikis. Oncogene. 37:6025–6040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lesuffleur T, Violette S, Vasile-Pandrea
I, Dussaulx E, Barbat A, Muleris M and Zweibaum A: Resistance to
high concentrations of methotrexate and 5-fluorouracil of
differentiated HT-29 colon-cancer cells is restricted to cells of
enterocytic phenotype. Int J Cancer. 76:383–392. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Longley DB and Johnston PG: Molecular
mechanisms of drug resistance. J Pathol. 205:275–292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia H, Ooi LL and Hui KM:
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets
PTEN and SMAD7 to promote drug resistance and recurrence of liver
cancer. Hepatology. 58:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahmed D, Eide PW, Eilertsen IA, Danielsen
SA, Eknæs M, Hektoen M, Lind GE and Lothe RA: Epigenetic and
genetic features of 24 colon cancer cell lines. Oncogenesis.
2:e712013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Boxtel R, Kuiper RV, Toonen PW, van
Heesch S, Hermsen R, de Bruin A and Cuppen E: Homozygous and
heterozygous p53 knockout rats develop metastasizing sarcomas with
high frequency. Am J Pathol. 179:1616–1622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu M, Xu Y, Ge M, Gui Z and Yan F:
Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell
proliferation and apoptosis. Cancer Sci. 106:833–839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang M, Gao Q, Chen Y, Li Z, Yue L and Cao
Y: PAK4, a target of miR-9-5p, promotes cell proliferation and
inhibits apoptosis in colorectal cancer. Cell Mol Biol Lett.
24:582019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahmed SM, Ramani PD, Wong SQR, Zhao X,
Ivanyi-Nagy R, Leong TC, Chua C, Li Z, Hentze H, Tan IB, et al: The
chromatin structuring protein HMGA2 influences human subtelomere
stability and cancer chemosensitivity. PLoS One. 14:e02156962019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dangi-Garimella S, Sahai V, Ebine K, Kumar
K and Munshi HG: Three-dimensional collagen I promotes gemcitabine
resistance in vitro in pancreatic cancer cells through
HMGA2-dependent histone acetyltransferase expression. PLoS One.
8:e645662013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao X, Peter S, Dröge P and Yan J:
Oncofetal HMGA2 effectively curbs unconstrained (+) and (−) DNA
supercoiling. Sci Rep. 7:84402017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsavaris N, Lazaris A, Kosmas C, Gouveris
P, Kavantzas N, Kopterides P, Papathomas T, Agrogiannis G, Zorzos
H, Kyriakou V and Patsouris E: Topoisomerase I and IIalpha protein
expression in primary colorectal cancer and recurrences following
5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother
Pharmacol. 64:391–398. 2009. View Article : Google Scholar : PubMed/NCBI
|
